{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:29:35Z","timestamp":1786735775009,"version":"build-2736575974"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Circ"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/bc.bc_35_19","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T19:11:10Z","timestamp":1569870670000},"page":"134","source":"Crossref","is-referenced-by-count":2,"title":["Activity of p53 in human amniotic fluid stem cells increases their potentiality as a candidate for stem cell therapy"],"prefix":"10.4103","volume":"5","author":[{"given":"Liborio","family":"Stuppia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaise","family":"Cozene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Antonucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2394-8108.268362-1","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1089\/scd.2017.0254","article-title":"P53 is active in human amniotic fluid stem cells","author":"Rodrigues","year":"2018","journal-title":"Stem Cells Dev"},{"key":"key-10.4103\/2394-8108.268362-2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1472-6483(10)60111-3","article-title":"Stem cells derived from amniotic fluid: New potentials in regenerative medicine","author":"Cananzi","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"key-10.4103\/2394-8108.268362-3","doi-asserted-by":"crossref","first-page":"e1662","DOI":"10.1038\/cddis.2015.33","article-title":"P53 is active in murine stem cells and alters the transcriptome in a manner that is reminiscent of mutant p53","author":"Yan","year":"2015","journal-title":"Cell Death Dis"},{"key":"key-10.4103\/2394-8108.268362-4","doi-asserted-by":"crossref","unstructured":"Olivos DJ, Mayo LD. Emerging non-canonical functions and regulation by p53: P53 and stemness. Int J Mol Sci 2016;17. pii: E1982.","DOI":"10.3390\/ijms17121982"},{"key":"key-10.4103\/2394-8108.268362-5","doi-asserted-by":"crossref","first-page":"e1001268","DOI":"10.1371\/journal.pbio.1001268","article-title":"P53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells","author":"Jain","year":"2012","journal-title":"PLoS Biol"},{"key":"key-10.4103\/2394-8108.268362-6","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/stem.1925","article-title":"P53 loss increases the osteogenic differentiation of bone marrow stromal cells","author":"He","year":"2015","journal-title":"Stem Cells"},{"key":"key-10.4103\/2394-8108.268362-7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/10409230903401507","article-title":"Regulation of p53 \u2013 Insights into a complex process","author":"Boehme","year":"2009","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"key-10.4103\/2394-8108.268362-8","first-page":"6304","article-title":"Participation of p53 protein in the cellular response to DNA damage","author":"Kastan","year":"1991","journal-title":"Cancer Res"},{"key":"key-10.4103\/2394-8108.268362-9","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.onc.1202436","article-title":"P53-dependent and -independent links between DNA-damage, apoptosis and mutation frequency in ES cells","author":"Corbet","year":"1999","journal-title":"Oncogene"},{"key":"key-10.4103\/2394-8108.268362-10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1242\/dev.128.1.137","article-title":"DNA damage-induced neural precursor cell apoptosis requires p53 and caspase 9 but neither bax nor caspase 3","author":"D'Sa-Eipper","year":"2001","journal-title":"Development"},{"key":"key-10.4103\/2394-8108.268362-11","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/sj.cdd.4401879","article-title":"Neural precursor cells possess multiple p53-dependent apoptotic pathways","author":"Akhtar","year":"2006","journal-title":"Cell Death Differ"},{"key":"key-10.4103\/2394-8108.268362-12","first-page":"116","article-title":"P53 is required for etoposide-induced apoptosis of human embryonic stem cells","author":"Grandela","year":"2007","journal-title":"Stem Cell Res"},{"key":"key-10.4103\/2394-8108.268362-13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","author":"Vogelstein","year":"2000","journal-title":"Nature"},{"key":"key-10.4103\/2394-8108.268362-14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","article-title":"Blinded by the light: The growing complexity of p53","author":"Vousden","year":"2009","journal-title":"Cell"},{"key":"key-10.4103\/2394-8108.268362-15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc2723","article-title":"The first 30 years of p53: Growing ever more complex","author":"Levine","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"key-10.4103\/2394-8108.268362-16","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1093\/emboj\/16.20.6217","article-title":"Regulation of ES cell differentiation by functional and conformational modulation of p53","author":"Sabapathy","year":"1997","journal-title":"EMBO J"},{"key":"key-10.4103\/2394-8108.268362-17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ceb.2005.09.007","article-title":"Transcription-independent pro-apoptotic functions of p53","author":"Moll","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"key-10.4103\/2394-8108.268362-18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4331\/wjbc.v2.i9.202","article-title":"P53 in stem cells","author":"Solozobova","year":"2011","journal-title":"World J Biol Chem"},{"key":"key-10.4103\/2394-8108.268362-19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1242\/dev.02208","article-title":"P53 suppresses the self-renewal of adult neural stem cells","author":"Meletis","year":"2006","journal-title":"Development"},{"key":"key-10.4103\/2394-8108.268362-20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.stem.2008.11.006","article-title":"P53 regulates hematopoietic stem cell quiescence","author":"Liu","year":"2009","journal-title":"Cell Stem Cell"},{"key":"key-10.4103\/2394-8108.268362-21","first-page":"119","article-title":"Amniotic fluid-derived stem cells as an effective cell source for transplantation therapy in stroke","author":"Diaco","year":"2015","journal-title":"Brain Circ","ISSN":"https:\/\/id.crossref.org\/issn\/2394-8108","issn-type":"print"},{"key":"key-10.4103\/2394-8108.268362-22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.cr.7310043","article-title":"Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential","author":"Bossolasco","year":"2006","journal-title":"Cell Res"},{"key":"key-10.4103\/2394-8108.268362-23","first-page":"100","article-title":", Siddiqui MM, Xu T, Santos CC, Perin L, et al. Isolation of amniotic stem cell lines with potential for therapy","author":"De","year":"2007","journal-title":"Nat Biotechnol"},{"key":"key-10.4103\/2394-8108.268362-24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.32607\/20758251-2009-1-2-98-103","article-title":"Cell phenotypes in human amniotic fluid","author":"Davydova","year":"2009","journal-title":"Acta Naturae"},{"key":"key-10.4103\/2394-8108.268362-25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature22312","article-title":"Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations","author":"Merkle","year":"2017","journal-title":"Nature"},{"key":"key-10.4103\/2394-8108.268362-26","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.stemcr.2016.10.003","article-title":"Detecting genetic mosaicism in cultures of human pluripotent stem cells","author":"Baker","year":"2016","journal-title":"Stem Cell Reports"},{"key":"key-10.4103\/2394-8108.268362-27","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/mt.2012.117","article-title":"Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach","author":"Moschidou","year":"2012","journal-title":"Mol Ther"},{"key":"key-10.4103\/2394-8108.268362-28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3727\/096368910X536518","article-title":"Human mesenchymal stem cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion","author":"Poloni","year":"2011","journal-title":"Cell Transplant"},{"key":"key-10.4103\/2394-8108.268362-29","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1089\/scd.2016.0356","article-title":"P53 mutation and epigenetic imprinted IGF2\/H19 gene analysis in mesenchymal stem cells derived from amniotic fluid, amnion, endometrium, and Wharton's Jelly","author":"Phermthai","year":"2017","journal-title":"Stem Cells Dev"},{"key":"key-10.4103\/2394-8108.268362-30","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/sj.onc.1204383","article-title":"AP-1 in cell proliferation and survival","author":"Shaulian","year":"2001","journal-title":"Oncogene"},{"key":"key-10.4103\/2394-8108.268362-31","first-page":"1367","article-title":"Regulation of insulin-like growth factor II P3 promotor by p53: A potential mechanism for tumorigenesis","author":"Zhang","year":"1996","journal-title":"Cancer Res"},{"key":"key-10.4103\/2394-8108.268362-32","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1210\/endo.139.3.5832","article-title":"P53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: Interaction between p53 and sp1","author":"Ohlsson","year":"1998","journal-title":"Endocrinology"},{"key":"key-10.4103\/2394-8108.268362-33","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/emmm.201101105","article-title":"Igf2 pathway dependency of the trp53 developmental and tumour phenotypes","author":"Haley","year":"2012","journal-title":"EMBO Mol Med"},{"key":"key-10.4103\/2394-8108.268362-34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2121-10-46","article-title":"Nuclear accumulation and activation of p53 in embryonic stem cells after DNA damage","author":"Solozobova","year":"2009","journal-title":"BMC Cell Biol"},{"key":"key-10.4103\/2394-8108.268362-35","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1128\/MCB.5.10.2851","article-title":"P53 cellular tumor antigen: Analysis of mRNA levels in normal adult tissues, embryos, and tumors","author":"Rogel","year":"1985","journal-title":"Mol Cell Biol"},{"key":"key-10.4103\/2394-8108.268362-36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ncb1211","article-title":"P53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression","author":"Lin","year":"2005","journal-title":"Nat Cell Biol"},{"key":"key-10.4103\/2394-8108.268362-37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molcel.2017.04.006","article-title":"DNA damage in stem cells","author":"Vitale","year":"2017","journal-title":"Mol Cell"},{"key":"key-10.4103\/2394-8108.268362-38","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s12015-013-9436-5","article-title":"Wnt signaling behaves as a \u201cmaster regulator\u201d in the osteogenic and adipogenic commitment of human amniotic fluid mesenchymal stem cells","author":"D'Alimonte","year":"2013","journal-title":"Stem Cell Rev Rep"},{"key":"key-10.4103\/2394-8108.268362-39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/bc.bc_36_18","article-title":"Treatment for ischemic stroke: From thrombolysis to thrombectomy and remaining challenges","author":"Leng","year":"2019","journal-title":"Brain Circ","ISSN":"https:\/\/id.crossref.org\/issn\/2394-8108","issn-type":"print"},{"key":"key-10.4103\/2394-8108.268362-40","first-page":"121","article-title":"Recent progress in regenerative medicine for brain disorders","author":"Anthony","year":"2017","journal-title":"Brain Circ","ISSN":"https:\/\/id.crossref.org\/issn\/2394-8108","issn-type":"print"},{"key":"key-10.4103\/2394-8108.268362-41","first-page":"86","article-title":"Regeneration after stroke: Stem cell transplantation and trophic factors","author":"Chau","year":"2016","journal-title":"Brain Circ","ISSN":"https:\/\/id.crossref.org\/issn\/2394-8108","issn-type":"print"},{"key":"key-10.4103\/2394-8108.268362-42","first-page":"167","article-title":"Amniotic fluid stem cell models: A tool for filling the gaps in knowledge for human genetic diseases","author":"Antonucci","year":"2017","journal-title":"Brain Circ","ISSN":"https:\/\/id.crossref.org\/issn\/2394-8108","issn-type":"print"},{"key":"key-10.4103\/2394-8108.268362-43","first-page":"152","article-title":"Drug treatments that optimize endogenous neurogenesis as a therapeutic option for stroke","author":"Dewan","year":"2017","journal-title":"Brain Circ","ISSN":"https:\/\/id.crossref.org\/issn\/2394-8108","issn-type":"print"},{"key":"key-10.4103\/2394-8108.268362-44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/2394-8108.178548","article-title":"Methylene blue treatment in experimental ischemic stroke: A mini review","author":"Jiang","year":"2016","journal-title":"Brain Circ","ISSN":"https:\/\/id.crossref.org\/issn\/2394-8108","issn-type":"print"},{"key":"key-10.4103\/2394-8108.268362-45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/bc.bc_24_17","article-title":"Amniotic fluid as a source of engraftable stem cells","author":"Borlongan","year":"2017","journal-title":"Brain Circ","ISSN":"https:\/\/id.crossref.org\/issn\/2394-8108","issn-type":"print"},{"key":"key-10.4103\/2394-8108.268362-46","first-page":"212","article-title":"Ischemic conditioning in organ transplant","author":"Kristin","year":"2018","journal-title":"Cond Med"},{"key":"key-10.4103\/2394-8108.268362-47","first-page":"143","article-title":"Conditioning against the pathology of Parkinson's disease","author":"Leak","year":"2018","journal-title":"Cond Med"},{"key":"key-10.4103\/2394-8108.268362-48","first-page":"187","article-title":"Differences and similarities in neuroprotective molecular pathways activated by distinct preconditioning inducers","author":"Cuomo","year":"2018","journal-title":"Cond Med"},{"key":"key-10.4103\/2394-8108.268362-49","first-page":"151","article-title":"A dual role for hyperbaric oxygen in stroke neuroprotection: Preconditioning of the brain and stem cells","author":"Liska","year":"2018","journal-title":"Cond Med"}],"container-title":["Brain Circulation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:33:27Z","timestamp":1786732407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/bc.bc_35_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"alternative-id":["268362"],"URL":"https:\/\/doi.org\/10.4103\/bc.bc_35_19","relation":{},"ISSN":["2394-8108"],"issn-type":[{"value":"2394-8108","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}